# Hicicare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hicicare

- Industry: Medical Devices & Equipment
- Headquarters: Guangzhou, China
- Website: www.hicicarescience.com
- Total disclosed funding: $14M
- Latest round: Series A (Dec 7, 2023)
- Investors on record: 5

## About

Founded in 2019 and based in Guangzhou, China, Hicicare is a medical technology company that focuses on the research and development of vascular and endovascular interventional medical devices. In December 2023, the firm closed a series A funding. As of 2023, the company has applied for 16 patents and has authorized 8 patents, including 1 invention patent.

The company's main products include implantable cardiac pacemakers, aortic stent grafts, intramedullary nails and internal artery stent systems. Implantable pacemakers provide services such as sleep apnea monitoring and SafeR physiological pacing. The company's products are used in three major vascular interventional fields: neurological, peripheral and coronary artery.

## Funding rounds

- Series A, Dec 7, 2023, $14M — Qiaojing Capital, Chiron Ventures, Rongtong Capital, Zhejiang Innovative and Developing Capital, Hongcheng Investment Management

## Investors

- Qiaojing Capital (https://capitalatlas.ai/funds/qiaojing-capital) — Series A
- Chiron Ventures — Series A
- Rongtong Capital — Series A
- Zhejiang Innovative and Developing Capital (https://capitalatlas.ai/funds/zhejiang-innovative-and-developing-capital) — Series A
- Hongcheng Investment Management (https://capitalatlas.ai/funds/hongcheng-investment-management) — Series A